-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Why Is Acumen (ABOS) Stock Up 95% Today?
Why Is Acumen (ABOS) Stock Up 95% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Acumen Pharmaceuticals (NASDAQ:ABOS) stock is rocketing higher on Wednesday but it's not due to any news from the company.
Instead, investors have Biogen (NASDAQ:BIIB) to thank for the increase of ABOS stock's price. That's due to the company revealing positive data from its clinical trial of Alzheimer's disease drug lecanemab.
Biogen is working on this new drug alongside Eisai (OTCMKTS:ESALY). The clinical trial results show the drug was successful at slowing the progression of early Alzheimer's by 27% when compared to a placebo.
That news resulted in analysts weighing in on BIIB stock again. As a result, several analysts increased their price targets for the shares. This has BIIB stock rising, but is also boosting other companies in the industry.
How is ABOS Stock Connected?
That's where ABOS stock comes in. Acumen Pharmaceuticals is developing its own treatments for Alzheimer's disease. While it's not directly connected to the Biogen news, shares are rising in sympathy with BIIB stock.
As a result, heavy trading has some 43 million shares of ABOS stock on the move today. That's a massive surge compared to its daily average trading volume of about 56,000 shares.
ABOS stock is up 94.5% as of Wednesday afternoon.
There's more hot stock market news that traders need to know about below!
We've got all of the latest stock market coverage investors need to know about for Wednesday! That includes what has shares of Silo Pharma (NASDAQ:SILO), BTRS (NASDAQ:BTRS), and Casava Sciences (NASDAQ:SAVA) stock on the move today. You can get up to speed on all of this news at the following links!
More Stock Market News for Wednesday
- What Is Going on With Silo Pharma (SILO) Stock Today?
- BTRS Stock Soars 60% on Acquisition News
- Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
The post Why Is Acumen (ABOS) Stock Up 95% Today? appeared first on InvestorPlace.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
投資者廣場-股市新聞、股票建議及交易提示
Acumen Pharmaceuticals (NASDAQ:ABOS) stock is rocketing higher on Wednesday but it's not due to any news from the company.
敏銳藥品 （納斯達克：ABOS）股票在星期三飆升，但這不是由於該公司的任何消息。
Instead, investors have Biogen (NASDAQ:BIIB) to thank for the increase of ABOS stock's price. That's due to the company revealing positive data from its clinical trial of Alzheimer's disease drug lecanemab.
相反，投資者有 生物（納斯達克：BIIB）感謝 ABOS 股票價格的上漲。這是由於該公司揭示了其阿爾茨海默氏病藥物講座的臨床試驗中的積極數據。
Biogen is working on this new drug alongside Eisai (OTCMKTS:ESALY). The clinical trial results show the drug was successful at slowing the progression of early Alzheimer's by 27% when compared to a placebo.
生物原正在研究這種新藥 永齋(支持:伊莎利).臨床試驗結果表明，與安慰劑相比，該藥物成功地將早期阿爾茨海默氏症的進展減緩了 27％。
That news resulted in analysts weighing in on BIIB stock again. As a result, several analysts increased their price targets for the shares. This has BIIB stock rising, but is also boosting other companies in the industry.
這一消息導致分析師再次沉重 BIIB 股票。其結果是，幾位分析師提高了他們的股票價格目標。這使 BIIB 股票上漲，但也促進了行業中的其他公司。
How is ABOS Stock Connected?
ABOS 股票如何連接？
That's where ABOS stock comes in. Acumen Pharmaceuticals is developing its own treatments for Alzheimer's disease. While it's not directly connected to the Biogen news, shares are rising in sympathy with BIIB stock.
這就是 ABOS 股票進來的地方。敏銳藥品正在開發自己的阿爾茨海默氏病治療方法。儘管它與 Biogen 新聞沒有直接關聯，但股票對 BIIB 股票的同情正在上升。
As a result, heavy trading has some 43 million shares of ABOS stock on the move today. That's a massive surge compared to its daily average trading volume of about 56,000 shares.
結果，大量交易今天在移動中擁有約 4300 萬股 ABOS 股票。與其每日平均交易量約 56,000 股相比，這是一個巨大的激增。
ABOS stock is up 94.5% as of Wednesday afternoon.
截至星期三下午，ABOS 股票上漲了 94.5%。
There's more hot stock market news that traders need to know about below!
交易者需要了解以下更多熱門股市新聞！
We've got all of the latest stock market coverage investors need to know about for Wednesday! That includes what has shares of Silo Pharma (NASDAQ:SILO), BTRS (NASDAQ:BTRS), and Casava Sciences (NASDAQ:SAVA) stock on the move today. You can get up to speed on all of this news at the following links!
我們已經擁有投資者需要了解的所有最新股市報導週三！這包括什麼股份 筒倉製藥（納斯達克：筒倉), BTRS（納斯達克：BTRS)，以及 卡薩瓦科學（納斯達克：薩瓦河）股票在移動今天。您可以通過以下鏈接了解所有這些新聞！
More Stock Market News for Wednesday
更多股市消息週三
- What Is Going on With Silo Pharma (SILO) Stock Today?
- BTRS Stock Soars 60% on Acquisition News
- Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
- 今天是怎麼回事與筒倉製藥公司 (SILO) 股票?
- BTRS 股票收購新聞飆升 60%
- 為什麼木薯科學（SAVA）庫存今天升溫？
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版之日，威廉·懷特本文所述證券沒有（直接或間接）任何持倉。本文中表達的意見是作者的意見，受到投資者的影響。出版指南。
The post Why Is Acumen (ABOS) Stock Up 95% Today? appeared first on InvestorPlace.
後為什麼智慧（ABOS）今天股票上漲了 95％？首次出現在投資廣場。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧